RACHEL NAIDEN: Open Payments
NPI 1033805585 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 85 payments from 24 companies in 2025. Trend: 2023 $614 · 2024 $1,497 · 2025 $1,791
Food & beverage: $1,791
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $302 |
| Janssen Biotech, Inc. | 13 | $287 |
| Novartis Pharmaceuticals Corporation | 11 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Incyte Corporation | 4 | $92 |
| Eisai Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Pharmacosmos Therapeutics Inc. | 3 | $68 |
| Genmab U.S., Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
Products named: Enhertu, ERLEADA, DATROWAY, TALVEY, MONJUVI, Lenvima, PLUVICTO, MONOFERRIC.
Industry payments across PA — which companies pay providers there.
